Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
Clinical trial NCT04004975 · UNKNOWN
Trial details
- NCT number
- NCT04004975
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2020-07-25
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.